<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pulmonary arteriovenous malformations: Epidemiology, etiology, and pathology in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pulmonary arteriovenous malformations: Epidemiology, etiology, and pathology in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pulmonary arteriovenous malformations: Epidemiology, etiology, and pathology in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Justin McWilliams, MD, FSIR</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jess Mandel, MD, MACP, ATSF, FRCP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 04, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Pulmonary arteriovenous malformations (PAVMs), also known as pulmonary arteriovenous fistulae, are abnormal communications between pulmonary artery and pulmonary vein, lacking the normal intervening capillary bed and resulting in right-to-left shunt [<a href="#rid1">1</a>]. PAVMs are uncommon in the general population, but they are an important consideration in the differential diagnosis of common pulmonary problems, including hypoxemia, pulmonary nodules, and hemoptysis. They should also be considered in patients presenting with paradoxical embolization, including cryptogenic stroke or brain abscess. PAVMs are a common occurrence in patients with hereditary hemorrhagic telangiectasia (HHT, also called Osler-Weber-Rendu syndrome).</p><p>The epidemiology, etiology, pathology, clinical features, and natural course of PAVMs are reviewed here. The diagnosis and treatment of PAVMs are discussed separately. (See  <a class="medical medical_review" href="/d/html/8268.html" rel="external">"Pulmonary arteriovenous malformations: Clinical features and diagnostic evaluation in adults"</a> and  <a class="medical medical_review" href="/d/html/16891.html" rel="external">"Therapeutic approach to adult patients with pulmonary arteriovenous malformations"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H177426868"><span class="h2">General population</span><span class="headingEndMark"> — </span>PAVMs are uncommon in the general population. This was illustrated by a study of 15,000 consecutive autopsies, in which only three cases of PAVMs were detected [<a href="#rid2">2</a>]. However, the prevalence may be higher than autopsy studies suggest. For example, in a study of over 21,000 screening computed tomography (CT) examinations, which allows detection of smaller PAVMs, the prevalence was approximately 1 per 2600 individuals [<a href="#rid3">3</a>].</p><p>PAVMs in the general population are 1.5 to 1.8 times as common among females, compared with males [<a href="#rid4">4</a>].</p><p>Among the general population, PAVMs are typically solitary (90 percent) and unilateral (97 percent) [<a href="#rid5">5</a>]. There is a lower lobe predilection, with at least two-thirds occurring in the lower lobes [<a href="#rid6">6,7</a>]. PAVMs tend to increase slowly in size over time and rarely regress spontaneously.</p><p class="headingAnchor" id="H177426874"><span class="h2">Hereditary hemorrhagic telangiectasia (HHT)</span><span class="headingEndMark"> — </span>Most PAVMs (80 to 90 percent) are associated with hereditary hemorrhagic telangiectasia (HHT, also called Osler-Weber-Rendu syndrome), an autosomal dominant genetic disorder characterized by abnormal blood vessel formation. Conversely, approximately 30 to 50 percent of patients with HHT will have PAVMs [<a href="#rid8">8</a>]. In patients with HHT, PAVMs are more evenly distributed by sex (56 percent female), more frequently multiple, and more evenly distributed throughout the lungs [<a href="#rid9">9</a>].</p><p>PAVM screening is recommended for patients with HHT [<a href="#rid10">10</a>]. Screening for PAVMs and the clinical manifestations and treatment of HHT are discussed separately. (See  <a class="medical medical_review" href="/d/html/1345.html" rel="external">"Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)"</a> and  <a class="medical medical_review" href="/d/html/16891.html" rel="external">"Therapeutic approach to adult patients with pulmonary arteriovenous malformations"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Most PAVMs are congenital and due to hereditary hemorrhagic telangiectasia (HHT). However PAVMs can occur in a variety of acquired medical conditions, the most common of which is hepatic cirrhosis (<a class="graphic graphic_table graphicRef102807" href="/d/graphic/102807.html" rel="external">table 1</a>) [<a href="#rid11">11</a>].</p><p>Less common associations include penetrating chest trauma, mitral stenosis, schistosomiasis, actinomycosis, Fanconi syndrome, and metastatic thyroid carcinoma [<a href="#rid12">12,13</a>]. PAVMs are also a well-established complication following surgery for congenital heart disease in children, including the classic Glenn shunt [<a href="#rid14">14</a>] and bidirectional cavopulmonary anastomosis [<a href="#rid15">15</a>]. The mechanism by which these various medical conditions become associated with PAVM is unknown. The remainder of PAVMs are believed to be idiopathic [<a href="#rid16">16</a>].</p><p>The genetics and pathogenesis of HHT, an autosomal dominant disorder of variable penetrance, may also provide insights into the etiology of PAVM, the details of which are discussed separately. (See  <a class="medical medical_review" href="/d/html/1345.html" rel="external">"Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)", section on 'Pathophysiology'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">PATHOLOGY</span></p><p class="headingAnchor" id="H177426971"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>The precise cause of pulmonary arteriovenous malformation (PAVM) is unknown. However, numerous causes of PAVM have been proposed, including the following: aberrant transforming growth factor-beta signaling during vascular development, possibly involving endoglin or activin receptor-like kinase 1; a defect in terminal arterial loops that allows dilation of thin-walled capillary sacs; incomplete resorption of the vascular septae that separate the arterial and venous plexuses during fetal development; failure of capillary development during fetal development, followed by the progressive dilation of favored limbs of smaller plexuses, formation of multiloculated sacs, and rupture of intervening vascular walls; and, development of many small PAVMs consisting of a single artery-to-vein connection without an intervening plexus [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H177426977"><span class="h2">Pathology</span><span class="headingEndMark"> — </span>A PAVM is an abnormal connection between the pulmonary artery and pulmonary vein that lacks that normal capillary component that should exist between the pulmonary arterial and venous circulations of the lung.</p><p>A PAVM may appear macroscopically as a large, single or multi-lobulated sac, a plexiform mass of dilated vascular channels, or a dilated and tortuous direct anastomosis between an artery and vein [<a href="#rid17">17</a>].</p><p>Histologically, PAVMs are usually thin-walled, consisting of a single layer of endothelium and variable amounts of connective tissue stroma [<a href="#rid2">2</a>]. Calcification and mural thrombosis are occasionally seen.</p><p>PAVMs are classified as either simple or complex. Simple PAVMs are perfused by arteries arising from a single subsegmental artery, whereas complex PAVMs are perfused by more than one subsegmental artery. Eighty to 95 percent of PAVMs are simple [<a href="#rid16">16,18</a>]. Small microvascular PAVMs (ie, telangiectases) are most commonly of the complex type [<a href="#rid19">19</a>].</p><p>PAVMs are supplied by pulmonary arteries in about 95 percent of cases and are usually drained by pulmonary veins; however, they may occasionally be fed by systemic arteries (ie, the bronchial artery) and/or drain into the left atrium or inferior vena cava. When PAVMs are fed by systemic arteries, hereditary hemorrhagic telangiectasia (HHT) is usually not the cause of the PAVM.</p><p class="headingAnchor" id="H1843005"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Pulmonary arteriovenous malformations (PAVMs) are abnormal communications between pulmonary arteries and veins, lacking the normal intervening capillary bed. PAVMs are an important consideration in the differential diagnosis of common pulmonary problems, including hypoxemia, pulmonary nodules, hemoptysis, and paradoxical embolization. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>PAVMs are uncommon in the general population. They are more common among females, compared with males, and are typically solitary with a lower lobe distribution. (See <a class="local">'General population'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Most PAVMs are associated with hereditary hemorrhagic telangiectasia (HHT, also called Osler-Weber-Rendu syndrome), with rates of underlying HHT exceeding 80 percent. In contrast, approximately 30 to 50 percent of patients with HHT have visible PAVMs on chest CT. (See <a class="local">'Hereditary hemorrhagic telangiectasia (HHT)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – Most PAVMs are congenital and secondary to HHT. PAVMs can also occur in a variety of acquired medical conditions (<a class="graphic graphic_table graphicRef102807" href="/d/graphic/102807.html" rel="external">table 1</a>), including hepatic cirrhosis, cardiothoracic surgery, penetrating chest trauma, mitral stenosis, schistosomiasis, actinomycosis, Fanconi syndrome, and metastatic thyroid carcinoma. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis and pathology</strong> – The precise cause of PAVM is unknown. PAVMs macroscopically appear as a large single or multilobulated sac, a plexiform mass of dilated vascular channels, or a dilated and tortuous direct anastomosis between an artery and vein. Histologically, PAVMs are usually thin-walled, consisting of a single layer of endothelium and variable amounts of connective tissue stroma. (See <a class="local">'Pathology'</a> above.)</p><p></p><p class="headingAnchor" id="H2892302625"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges James R Gossage, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Churton, T. Multiple aneurysms of the pulmonary artery. Br Med J 1897; 1:1223.</a></li><li><a class="nounderline abstract_t">SLOAN RD, COOLEY RN. Congenital pulmonary arteriovenous aneurysm. Am J Roentgenol Radium Ther Nucl Med 1953; 70:183.</a></li><li><a class="nounderline abstract_t">Nakayama M, Nawa T, Chonan T, et al. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med 2012; 51:1677.</a></li><li><a class="nounderline abstract_t">Cartin-Ceba R, Swanson KL, Krowka MJ. Pulmonary arteriovenous malformations. Chest 2013; 144:1033.</a></li><li><a class="nounderline abstract_t">Albitar HAH, Segraves JM, Almodallal Y, et al. Pulmonary Arteriovenous Malformations in Non-hereditary Hemorrhagic Telangiectasia Patients: An 18-Year Retrospective Study. Lung 2020; 198:679.</a></li><li><a class="nounderline abstract_t">White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996; 7:787.</a></li><li><a class="nounderline abstract_t">Remy-Jardin M, Dumont P, Brillet PY, et al. Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up. Radiology 2006; 239:576.</a></li><li><a class="nounderline abstract_t">Kaufman CS, McDonald J, Balch H, Whitehead K. Pulmonary Arteriovenous Malformations: What the Interventional Radiologist Should Know. Semin Intervent Radiol 2022; 39:261.</a></li><li><a class="nounderline abstract_t">Kroon S, van den Heuvel DAF, Vos JA, et al. Idiopathic and hereditary haemorrhagic telangiectasia associated pulmonary arteriovenous malformations: comparison of clinical and radiographic characteristics. Clin Radiol 2021; 76:394.e1.</a></li><li><a class="nounderline abstract_t">Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011; 48:73.</a></li><li><a class="nounderline abstract_t">Krowka MJ. Hepatopulmonary Syndrome and Portopulmonary Hypertension. Curr Treat Options Cardiovasc Med 2002; 4:267.</a></li><li><a class="nounderline abstract_t">Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122:521.</a></li><li><a class="nounderline abstract_t">Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998; 158:643.</a></li><li><a class="nounderline abstract_t">Mathur M, Glenn WW. Long-term evaluation of cava-pulmonary artery anastomosis. Surgery 1973; 74:899.</a></li><li><a class="nounderline abstract_t">Kim SJ, Bae EJ, Cho DJ, et al. Development of pulmonary arteriovenous fistulas after bidirectional cavopulmonary shunt. Ann Thorac Surg 2000; 70:1918.</a></li><li><a class="nounderline abstract_t">Wong HH, Chan RP, Klatt R, Faughnan ME. Idiopathic pulmonary arteriovenous malformations: clinical and imaging characteristics. Eur Respir J 2011; 38:368.</a></li><li><a class="nounderline abstract_t">BOSHER LH Jr, BLAKE DA, BYRD BR. An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms with particular reference to the applicability of local excision. Surgery 1959; 45:91.</a></li><li><a class="nounderline abstract_t">Pugash RA. Pulmonary arteriovenous malformations: overview and transcatheter embolotherapy. Can Assoc Radiol J 2001; 52:92.</a></li><li><a class="nounderline abstract_t">HALES MR. Multiple small arteriovenous fistulae of the lungs. Am J Pathol 1956; 32:927.</a></li></ol></div><div id="topicVersionRevision">Topic 8267 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Multiple aneurysms of the pulmonary artery</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13065567" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Congenital pulmonary arteriovenous aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22790125" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24008954" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Pulmonary arteriovenous malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32648120" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pulmonary Arteriovenous Malformations in Non-hereditary Hemorrhagic Telangiectasia Patients: An 18-Year Retrospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8951745" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16484354" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36062221" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pulmonary Arteriovenous Malformations: What the Interventional Radiologist Should Know.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33648759" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Idiopathic and hereditary haemorrhagic telangiectasia associated pulmonary arteriovenous malformations: comparison of clinical and radiographic characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19553198" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12003725" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hepatopulmonary Syndrome and Portopulmonary Hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7872588" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The hepatopulmonary syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9700146" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pulmonary arteriovenous malformations. A state of the art review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4127196" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Long-term evaluation of cava-pulmonary artery anastomosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11156095" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Development of pulmonary arteriovenous fistulas after bidirectional cavopulmonary shunt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21177836" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Idiopathic pulmonary arteriovenous malformations: clinical and imaging characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13624986" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms with particular reference to the applicability of local excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11339152" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pulmonary arteriovenous malformations: overview and transcatheter embolotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13354716" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Multiple small arteriovenous fistulae of the lungs.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
